Profound Medical Corp. Overview
Pro stress-test →Profound Medical Corp is a medical technology company focused on a therapeutics platform that provides the precision of real-time Magnetic Resonance Imaging combined with the safety and ablation power of directional and focused ultrasound technology for the incision-free ablation of diseased tissue. The company is commercializing TULSA-PRO for prostate treatment and Sonalleve for soft tissue applications across multiple markets.
Strategic Profile
Pro stress-test →Profound is commercializing TULSA-PRO, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control with potential to become a mainstream treatment modality across the entire prostate disease spectrum. The company recently regained exclusive distribution rights for TULSA-PRO in Canada.
Competitive Landscape
Pro stress-test →Profound Medical competes in the minimally-invasive therapeutic ablation space. Key competitors include focused ultrasound and thermal ablation device makers targeting prostate, soft tissue and oncology applications. The company differentiates through real-time MRI guidance and AI-enhanced planning for precision ablation.
Industry Context
Profound Medical Corp. operates in Medical Devices - Minimally Invasive Therapeutics.
Key facts
Founded: 2008 · Headquarters: Mississauga, Ontario, Canada · Revenue: $10.68M (2024)